Duration of extracorporeal therapy in acute maple syrup urine disease: A kinetic model

Pediatric Nephrology

Volumn 21, Issue 5, 2006, Pages 698-704

  Phan, Véronique ^a   Clermont, Marie José ^a   Merouani, Aicha ^a   Litalien, Catherine ^a   Tucci, Marisa ^a   Lambert, Marie ^a   Mitchell, Grant ^a   Jouvet, Philippe ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Amino acid metabolism; Hemodialysis; Hemofiltration; Inborn error of metabolism; Kinetic modelling; Leucine clearance; Maple syrup urine disease

Indexed keywords

LEUCINE;

ACUTE DISEASE; ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN EDEMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMODYNAMICS; HUMAN; INFANT; KINETICS; MALE; MAPLE SYRUP URINE DISEASE; MODEL; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; PREDICTION; PRIORITY JOURNAL; VALIDATION STUDY;

ACUTE DISEASE; ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LEUCINE; MALE; MAPLE SYRUP URINE DISEASE; MODELS, BIOLOGICAL; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33646127162     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0044-3     Document Type: Article

References (15)

1. Thompson GN, Bresson JL, Pacy PJ, Bonnefont JP, Walter JH, Leonard JV, Saudubray JM, Halliday D (1990) Protein and leucine metabolism in maple syrup urine disease. Am J Physiol 258(4 Pt 1):E654-E660
2. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U (2001) Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Pediatr Res 49(5):627-635
3. Schadewaldt P, Hammen HW, Ott AC, Wendel U (1999) Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis 22(6):706-722
4. Hilliges C, Awiszus D, Wendel U (1993) Intellectual performance of children with maple syrup urine disease. Eur J Pediatr 152(2):144-147
5. Jouvet P, Hubert P, Saudubray JM, Rabier D, Man NK (2005) Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease. Pediatr Res 58:278-282
6. Jouvet P, Jugie M, Rabier D, Desgres J, Hubert P, Saudubray JM, Man NK (2001) Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med 27(11):1798-1806
7. Fiser DH (1992) Assessing the outcome of pediatric intensive care. J Pediatr 121(1):68-74
8. Sharkey I, Boddy AV, Wallace H, Mycroft J, Hollis R, Picton S (2001) Body surface area estimation in children using weight alone: Application in paediatric oncology. Br J Cancer 85(1):23-28
9. Butte NF, Hopkinson JM, Wong WW, Smith EO, Ellis KJ (2000) Body composition during the first 2 years of life: An updated reference. Pediatr Res 47(5):578-585
10. Flynn JT (2002) Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 17(1):61-69
11. Gouyon JB, Desgres J, Mousson C (1994) Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: Implications for maple syrup urine disease treatment. Pediatr Res 35(3):357-361
12. Gouyon JB, Francoise M, Desgres J, Petion AM, Sandre D (1994) Removal of amino acids by continuous hemofiltration and hemodiafiltration. Arch Pediatr 1(5):501-504
13. Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14(4):910-918
14. Sadowski RH, Harmon WE, Jabs K (1994) Acute hemodialysis of infants weighing less than five kilograms. Kidney Int 45(3):903-906
15. Rajpoot DK, Gargus JJ (2004) Acute hemodialysis for hyperammonemia in small neonates. Pediatr Nephrol 19(4):390-395